Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis
Part of paid clinical trials in Toledo, Ohio.
- Sponsor
- ProMedica Health System
- Study ID
- NCT07356284
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Acute Ischemic Stroke
- Brain Stroke
- Stenting Treatment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mechanical Thrombectomy plus adjunct stenting — PROCEDUREMechanical thrombectomy and adjunct stentiing
- Mechanical Thrombectomy — DEVICEMechanical thrombectomy only
Study Details
The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.
Key Dates
- Start date
- May 19, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 1, 2030
- Completion
- Jun 1, 2030
Study Design
- Enrollment
- 342 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Randomized to Mechanical Thrombectomy (MT) plus adjunct StentingPatients will have mechanical thrombectomy (MT) and stenting
- Active Comparator: Randomized to Mechanical Thrombectomy (MT)Patients will only have mechanical thrombectomy (MT) done
Primary Outcome Measure
Primary Efficacy Endpoint [ Time Frame: 90 (+/- 30) days post treatment ]
Central Contacts
- Sami Al Kasab, MD4192913498
- Mouhammad Jumaa, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ProMedica Toledo Hospital | Toledo | Ohio | 43606 | Scalzo Mouhammad Jumaa, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Toledo, OH
By condition
By specialty
By research site
Related Studies
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy TrialPHASE3 · Recruiting · Mercy Health Ohio · Mobile, Alabama
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokePHASE3 · Recruiting · Pharmazz, Inc. · Tuscon, Arizona
- Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)PHASE2 · Recruiting · Basking Biosciences, Inc. · Scottsdale, Arizona
- Optimizing Reperfusion to Improve Outcomes and Neurologic FunctionPHASE2/PHASE3 · Recruiting · Corxel Pharmaceuticals · Long Beach, California